Correction: Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis

Letícia F. Leal; Ana Carolina Bueno; Débora C. Gomes; Rafael Abduch; Margaret de Castro; Sonir R. Antonini

doi:10.18632/oncotarget.28472

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis

PDF | How to cite

Oncotarget. 2023; 14:700-700. https://doi.org/10.18632/oncotarget.28472

Metrics: PDF 576 views | ?

Letícia F. Leal¹, Ana Carolina Bueno¹, Débora C. Gomes^1,2, Rafael Abduch¹, Margaret de Castro³ and Sonir R. Antonini¹

¹Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
²Department of Pediatrics, School of Medicine, Federal University of Uberlandia, Uberlândia, Minas Gerais, Brazil
³Department of Internal Medicine, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil

Published: July 07, 2023

Copyright: © 2023 Leal et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: The Grant Support information has been updated. Please see the paragraph below:

GRANT SUPPORT

This research was supported by the Sao Paulo Research Foundation (FAPESP; LFL fellowship 2011/10512-3; Grants 2007/58365-3 and 2011/13807-4) and the National Council of Technological and Scientific Development (CNPq; Grant 474273-2013-3). This manuscript also received funding from CAPES - Coordination for the Improvement of Higher Education Personnel.

Original article: Oncotarget. 2015; 6:43016–43032. DOI: https://doi.org/10.18632/oncotarget.5513

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28472

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis